Prospects for an Anticancer Vaccine
October 17, 2023 | Terry Sharrer
![](http://www.medicalautomation.org/wp-content/uploads/2023/10/Cytotoxic-CD8-T-cells-recognizing-cancer-cells-by-receptor-binding-neoantigens-Oct-17-300x200.jpeg)
Cytotoxic CD8+ T-cells recognizing cancer cells by receptor binding neoantigens
“Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response. If validated in clinical trials, the technology could help scientists overcome a major hurdle to developing personalized immunotherapies and vaccines. . . . . the cancer protein fragments that elicit this tumor-killing immune response may originate from changes in the genetic makeup of cancer cells (or mutations), called mutation-associated neoantigens.” MORE